question_id,date,category,question_text,baseline_success,baseline_actually_answered,baseline_has_expected,baseline_confidence,baseline_text,baseline_error,baseline_time,baseline_input_tokens,baseline_output_tokens,togomcp_success,togomcp_has_expected,togomcp_confidence,togomcp_text,togomcp_error,togomcp_time,togomcp_input_tokens,togomcp_output_tokens,togomcp_cache_creation_input_tokens,togomcp_cache_read_input_tokens,tools_used,tool_details,value_add,expected_answer,notes
1,2026-01-29,Precision,What is the UniProt accession ID for the CRISPR-associated endonuclease Cas9 from Streptococcus pyogenes serotype M1?,True,True,True,1.0,"The UniProt accession ID for the CRISPR-associated endonuclease Cas9 from Streptococcus pyogenes serotype M1 is **Q99ZW2**.

This is the widely studied Cas9 protein (also known as SpCas9) that has become the most commonly used variant in CRISPR-Cas9 gene editing applications. It comes from the Streptococcus pyogenes strain MGAS5005 (serotype M1).",,4.139670133590698,78,118,True,True,1.0,"The UniProt accession ID for the CRISPR-associated endonuclease Cas9 from Streptococcus pyogenes serotype M1 is **Q99ZW2**.

This protein is also known as:
- CRISPR-associated endonuclease Cas9/Csn1 
- SpCas9 or SpyCas9 (common abbreviations)
- EC 3.1.-.- (enzyme classification)

This is the well-known Cas9 enzyme that has become widely used in genome editing applications.",,12.717868089675903,9,263,26895,26520,mcp__togomcp__search_uniprot_entity,"[{""name"": ""mcp__togomcp__search_uniprot_entity"", ""input"": {""query"": ""Cas9 Streptococcus pyogenes serotype M1"", ""limit"": 10}}]",VALUABLE,Q99ZW2,"Database: UniProt. Tests precise protein identification. SpCas9 is the most widely used Cas9 variant in genome editing. Found via search_uniprot_entity('SpCas9 Streptococcus pyogenes'). Verified in uniprot_exploration.md. Requires actual search, not in MIE examples. Expert-relevant: Essential for CRISPR research and gene therapy applications."
2,2026-01-29,Precision,What is the MONDO disease ontology identifier for Fabry disease?,True,True,True,1.0,"The MONDO (Monarch Disease Ontology) identifier for Fabry disease is **MONDO:0010526**.

Fabry disease is an X-linked lysosomal storage disorder caused by deficiency of the enzyme alpha-galactosidase A, leading to accumulation of globotriaosylceramide in various tissues.",,4.144452810287476,52,79,True,True,1.0,"The MONDO disease ontology identifier for Fabry disease is **MONDO:0010526**.

According to the MONDO ontology, Fabry disease (FD) is defined as ""a progressive, inherited, multisystemic lysosomal storage disease characterized by specific neurological, cutaneous, renal, cardiovascular, cochleo-vestibular and cerebrovascular manifestations."" It is classified as a sphingolipidosis and inherited lipid metabolism disorder.",,15.172627925872803,8,216,43194,26494,mcp__ols__searchClasses,"[{""name"": ""mcp__ols__searchClasses"", ""input"": {""query"": ""Fabry disease"", ""ontologyId"": ""mondo""}}]",VALUABLE,MONDO:0010526,Database: MONDO. Tests rare disease identification in ontology databases. Fabry disease is a lysosomal storage disorder (alpha-galactosidase A deficiency). Found via OLS4 searchClasses. Verified in mondo_exploration.md. Requires database lookup; baseline cannot provide specific ontology IDs. Expert-relevant: Critical for orphan drug development and clinical genetics research.
3,2026-01-29,Completeness,How many reviewed (Swiss-Prot) human proteins are annotated in UniProt?,True,False,True,1.0,"I don't have access to real-time UniProt database statistics, so I cannot provide the current exact number of reviewed (Swiss-Prot) human proteins.

However, based on my training knowledge (with a cutoff in April 2024), the number of reviewed human proteins in UniProt/Swiss-Prot was approximately **20,000-20,400** entries. This number grows slowly over time as new proteins are manually reviewed and added to Swiss-Prot.

For the most current and accurate count, I'd recommend:
1. Visiting the UniProt website (uniprot.org)
2. Using the query: `reviewed:true AND organism_id:9606` (where 9606 is the taxonomy ID for Homo sapiens)
3. Checking the UniProt release notes, which document the exact numbers for each release

The Swiss-Prot portion of UniProt grows much more slowly than TrEMBL (unreviewed entries) because each entry undergoes manual curation and review.",,6.362957715988159,57,232,True,True,1.0,"According to the UniProt database, there are **20,435 reviewed (Swiss-Prot) human proteins** currently annotated.

Swiss-Prot is the manually annotated and reviewed section of UniProt, containing high-quality, non-redundant protein sequences with detailed functional annotation. These entries undergo expert curation and are considered the gold standard for protein annotation quality.",,13.33591604232788,9,290,567,52658,mcp__togomcp__run_sparql,"[{""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""uniprot"", ""sparql_query"": ""\nPREFIX up: <http://purl.uniprot.org/core/>\nPREFIX taxon: <http://purl.uniprot.org/taxonomy/>\n\nSELECT (COUNT(DISTINCT ?protein) AS ?count)\nWHERE {\n  ?protein a up:Protein ;\n           up:organism taxon:9606 ;\n           up:reviewed true .\n}\n""}}]",CRITICAL,"40,209 reviewed human proteins",Database: UniProt. Tests ability to count high-quality curated entries. Requires COUNT query with reviewed=1 and organism filters. Verified in uniprot_exploration.md via SPARQL COUNT query. Entity count (proteins). Baseline cannot provide exact current counts. Expert-relevant: Establishes scope of expertly curated human proteome for systematic analyses.
4,2026-01-29,Completeness,How many descendant terms does the Gene Ontology term 'autophagy' (GO:0006914) have?,True,False,True,1.0,"I don't have access to real-time Gene Ontology database information, so I cannot provide you with the current exact number of descendant terms for GO:0006914 (autophagy).

The number of descendant terms in the Gene Ontology changes over time as the ontology is regularly updated with new terms, refinements, and reorganizations. To get the current accurate count of descendant terms for autophagy (GO:0006914), you would need to:

1. Visit the Gene Ontology website (geneontology.org)
2. Use the AmiGO browser or QuickGO
3. Search for GO:0006914
4. Check the term details which typically show the number of child and descendant terms

As of my training data, autophagy is a well-developed branch of GO with numerous child terms covering different types of autophagy (macroautophagy, microautophagy, chaperone-mediated autophagy, etc.) and related processes, but I cannot give you a specific number without access to the current database.",,5.456760883331299,64,240,True,True,1.0,"The Gene Ontology term 'autophagy' (GO:0006914) has **25 descendant terms**.

From the results, I can see that these descendants include various types of autophagy processes, such as:
- **Macroautophagy** (GO:0016236) - with multiple subtypes like mitophagy, pexophagy, xenophagy, lipophagy, glycophagy, aggrephagy, etc.
- **Microautophagy** (GO:0016237) - including micropexophagy, micromitophagy, microlipophagy, and others
- **Chaperone-mediated autophagy** (GO:0061684)
- **Organelle-specific autophagy** such as autophagy of mitochondrion and peroxisome
- Other specialized types like crinophagy, nucleophagy, reticulophagy, and lysophagy

The query returned results paginated across 2 pages (showing 20 items per page initially), with a total of 25 descendant terms.",,14.598973989486694,8,392,13636,52665,mcp__ols__getDescendants,"[{""name"": ""mcp__ols__getDescendants"", ""input"": {""ontologyId"": ""go"", ""classIri"": ""http://purl.obolibrary.org/obo/GO_0006914""}}]",CRITICAL,25 descendant terms,"Database: GO. Tests ontology hierarchy navigation and counting. Requires OLS4 getDescendants query. Includes all subtypes like macroautophagy, microautophagy, etc. Verified in go_exploration.md. Entity count (GO terms). Requires database query, not documented in MIE. Expert-relevant: Essential for understanding the scope of autophagy-related processes in cell biology research."
5,2026-01-29,Integration,What is the NCBI Gene ID corresponding to UniProt accession P04637?,True,True,True,1.0,"The NCBI Gene ID corresponding to UniProt accession P04637 is **7157**.

This UniProt accession (P04637) corresponds to the human TP53 gene, which encodes the tumor protein p53, a crucial tumor suppressor protein involved in cell cycle regulation, DNA repair, and apoptosis.",,2.8303542137145996,56,76,True,True,1.0,"The NCBI Gene ID corresponding to UniProt accession **P04637** is **7157**.

This UniProt entry represents the human TP53 (tumor protein p53) gene, which is one of the most well-studied tumor suppressor genes in cancer research.",,11.58378791809082,8,186,478,52657,mcp__togomcp__togoid_convertId,"[{""name"": ""mcp__togomcp__togoid_convertId"", ""input"": {""ids"": ""P04637"", ""route"": ""uniprot,ncbigene""}}]",VALUABLE,7157,"Databases: UniProt, NCBI Gene. Tests cross-database ID conversion. P04637 is TP53 (tumor protein p53), one of the most important tumor suppressors. Requires togoid_convertId or cross-reference lookup. Verified in uniprot_exploration.md. Requires integration tools; baseline has limited cross-reference knowledge. Expert-relevant: Fundamental for integrating protein data with genomic and clinical information in cancer research."
6,2026-01-29,Integration,What is the ChEBI identifier for the immunosuppressive drug sirolimus (rapamycin)?,True,True,True,1.0,"The ChEBI identifier for sirolimus (rapamycin) is **CHEBI:9168**.

Sirolimus is indeed an immunosuppressive drug that is commonly used to prevent organ transplant rejection and has also found applications in other areas such as drug-eluting stents and treatment of certain conditions.",,2.2874841690063477,60,72,True,True,1.0,"Perfect! The ChEBI identifier for sirolimus (rapamycin) is **CHEBI:9168**.

Both ""sirolimus"" and ""rapamycin"" map to the same ChEBI identifier, which makes sense as they are synonymous names for the same immunosuppressive drug. The full URI is `http://purl.obolibrary.org/obo/CHEBI_9168`, which corresponds to the CURIE format **CHEBI:9168**.",,24.737875938415527,22,401,30116,71310,"mcp__pubdictionaries__find_ids, mcp__pubdictionaries__list_dictionaries, mcp__pubdictionaries__find_ids","[{""name"": ""mcp__pubdictionaries__find_ids"", ""input"": {""labels"": ""sirolimus, rapamycin"", ""dictionary"": ""ChEBI""}}, {""name"": ""mcp__pubdictionaries__list_dictionaries"", ""input"": {}}, {""name"": ""mcp__pubdictionaries__find_ids"", ""input"": {""labels"": ""sirolimus, rapamycin"", ""dictionary"": ""CHEBI""}}]",VALUABLE,CHEBI:9168,Database: ChEBI. Tests chemical entity identification across naming systems. Sirolimus/rapamycin is a macrolide with immunosuppressive and anti-cancer properties. Found via OLS4 searchClasses in ChEBI ontology. Verified in chebi_exploration.md. Requires database search; baseline may know the drug but not specific ontology ID. Expert-relevant: Essential for drug mechanism studies and repurposing analyses.
7,2026-01-29,Currency,How many protein structure entries are currently available in the PDB for CRISPR Cas9?,True,False,True,1.0,"I don't have access to real-time data about the current number of protein structure entries in the PDB (Protein Data Bank), as my training knowledge has a cutoff date and the PDB is continuously updated with new structures.

However, I can tell you that as of my last training data (April 2024), there were **hundreds** of CRISPR-Cas9 related structures in the PDB, including:

- Structures of Cas9 from different species (primarily *Streptococcus pyogenes* and *Staphylococcus aureus*)
- Cas9 in various functional states (apo, guide RNA-bound, DNA-bound, ternary complexes)
- Catalytically active and inactive variants
- Cas9 bound to different inhibitors and other proteins

The number has been growing rapidly since the first Cas9 structure was deposited around 2014.

To get the **current exact number**, you would need to:
1. Visit www.rcsb.org (the PDB website)
2. Search for ""CRISPR Cas9"" or ""Cas9""
3. Filter the results as needed

The count likely ranges from 200-400+ entries depending on how broadly you define ""Cas9-related"" structures, but I cannot give you the precise current number without accessing the database directly.",,8.295313119888306,58,309,True,True,1.0,"Based on the search results from the Protein Data Bank (PDB), there are currently **475 protein structure entries** available for CRISPR Cas9.

These structures include a wide variety of Cas9 systems and states:
- **SpCas9** (Streptococcus pyogenes Cas9) - the most commonly used variant
- **SpRY-Cas9** - an engineered variant with altered PAM specificity
- **FnCas9** (Francisella novicida Cas9)
- **SaCas9** (Staphylococcus aureus Cas9)
- **St1Cas9** (Streptococcus thermophilus Cas9)

The structures capture various functional states including:
- Cas9 bound to guide RNA (sgRNA/crRNA-tracrRNA)
- Cas9-RNA-DNA ternary complexes
- Different R-loop conformations (RNA-DNA hybrid states)
- PAM recognition states
- Catalytic and checkpoint states
- Complexes with anti-CRISPR proteins (AcrII)
- Cas9 variants engineered for different PAM sequences

This represents a substantial structural database that has been crucial for understanding the mechanism of CRISPR-Cas9 gene editing and for engineering improved variants.",,15.187358856201172,9,437,3636,52659,mcp__togomcp__search_pdb_entity,"[{""name"": ""mcp__togomcp__search_pdb_entity"", ""input"": {""db"": ""pdb"", ""query"": ""CRISPR Cas9"", ""limit"": 100}}]",CRITICAL,461 structures,Database: PDB. Tests access to current structural biology data. Requires search_pdb_entity with 'CRISPR Cas9' query. Number may increase as new structures are deposited. Verified in pdb_exploration.md. Baseline knowledge frozen at training cutoff; current count requires database access. Expert-relevant: Guides structure-based drug design and mechanistic studies of genome editing.
8,2026-01-29,Currency,How many biomedical articles about mRNA vaccines are indexed in PubMed?,True,False,True,0.6,"I don't have access to real-time PubMed data or the ability to query databases, so I cannot provide you with the current number of biomedical articles about mRNA vaccines indexed in PubMed.

However, I can tell you that:

1. **The number has grown substantially** since 2020-2021 due to the COVID-19 pandemic and the deployment of mRNA vaccines (like Pfizer-BioNTech and Moderna vaccines).

2. **Before COVID-19**, there were relatively few publications on mRNA vaccines, as the technology was still largely experimental.

3. **As of my training data** (with knowledge up to early 2024), there were likely thousands of articles on this topic, but the exact current count would require a direct PubMed search.

To find the current number yourself, you could:
- Go to PubMed (pubmed.ncbi.nlm.nih.gov)
- Search for terms like ""mRNA vaccine"" OR ""messenger RNA vaccine""
- The search results will show you the total count

The number continues to grow as research on mRNA vaccine technology, efficacy, safety, and new applications expands.",,6.903375148773193,55,266,True,False,0.0,"There are **17,521 biomedical articles** about mRNA vaccines indexed in PubMed.

This is a substantial body of literature, reflecting the significant research interest in mRNA vaccine technology, particularly accelerated by COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna), though research in this area predates the pandemic.",,11.592488050460815,8,161,520,52656,mcp__pubmed__search_articles,"[{""name"": ""mcp__pubmed__search_articles"", ""input"": {""query"": ""mRNA vaccines"", ""max_results"": 1}}]",CRITICAL,Current count (verify at query time),Database: PubMed. Tests access to current literature. mRNA vaccines are a rapidly evolving field post-COVID-19. Requires PubMed search_articles with 'mRNA vaccine' query. Count increases continuously with new publications. Verified in pubmed_exploration.md. Baseline frozen at Jan 2025; current literature requires database. Expert-relevant: Tracks research momentum in vaccine technology and identifies emerging trends.
9,2026-01-29,Specificity,What is the MeSH descriptor ID for Niemann-Pick disease?,True,True,True,1.0,"The MeSH descriptor ID for Niemann-Pick disease is **D009542**.

This descriptor covers Niemann-Pick diseases as a group of inherited lysosomal storage disorders characterized by sphingomyelin accumulation in various organs.",,2.0248818397521973,53,56,True,True,1.0,"The MeSH descriptor IDs for Niemann-Pick disease are:

1. **D009542** - **Niemann-Pick Diseases** (general term covering all types)
2. **D052536** - Niemann-Pick Disease, Type A
3. **D052537** - Niemann-Pick Disease, Type B
4. **D052556** - Niemann-Pick Disease, Type C

The main umbrella term ""Niemann-Pick Diseases"" has the MeSH ID **D009542**, while the specific subtypes (A, B, and C) have their own distinct descriptor IDs.",,13.373620986938477,9,248,605,52654,mcp__togomcp__search_mesh_descriptor,"[{""name"": ""mcp__togomcp__search_mesh_descriptor"", ""input"": {""query"": ""Niemann-Pick disease"", ""limit"": 10}}]",VALUABLE,D009542,Database: MeSH. Tests retrieval of medical terminology for rare lysosomal storage disorder. Found via search_mesh_descriptor('Niemann-Pick'). Verified in mesh_exploration.md. Requires database search; baseline unlikely to know specific MeSH IDs for rare diseases. Expert-relevant: Essential for systematic literature reviews and clinical trial recruitment in rare disease research.
10,2026-01-29,Specificity,What is the NANDO identifier for Parkinson's disease as designated in the Japanese intractable disease database?,True,False,False,0.0,"I don't have specific information about the NANDO identifier for Parkinson's disease in the Japanese intractable disease database in my training knowledge.

NANDO (Nanbyo Disease Ontology) is a database system used in Japan for cataloging intractable/rare diseases (nanbyo), but I cannot provide the specific identifier for Parkinson's disease with certainty without access to the actual database or reference materials that contain this information.

If you need this specific identifier, I would recommend checking the official NANDO database or the Japanese Ministry of Health, Labour and Welfare's resources on intractable diseases.",,3.774833917617798,61,136,True,True,1.0,"Perfect! I found the information you're looking for.

**The NANDO identifier for Parkinson's disease is: NANDO:1200010**

Additional details:
- **Notification Number**: 6 (this is the Japanese government's official designation number for this intractable disease)
- **English Label**: Parkinson's disease
- **Japanese Label**: パーキンソン病

The query also found two related conditions:
- **NANDO:1200524** - Rapid-onset dystonia-parkinsonism (Notification #120)
- **NANDO:1200036** - Multiple system atrophy, Parkinsonian type (Notification #17)

NANDO (Nanbyo Data) is the comprehensive ontology for Japanese intractable (rare) diseases maintained by the Japanese government, containing 2,777 disease classes with multilingual labels and cross-references to international disease ontologies.",,30.67960500717163,21,922,16133,121252,"mcp__togomcp__run_sparql, mcp__togomcp__get_MIE_file, mcp__togomcp__run_sparql","[{""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""nando"", ""sparql_query"": ""\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\nPREFIX dcterms: <http://purl.org/dc/terms/>\nPREFIX nando: <http://nanbyodata.jp/ontology/nando#>\n\nSELECT DISTINCT ?nando_id ?label ?description\nWHERE {\n  ?disease a nando:NANDO_0000001 ;\n           rdfs:label ?label ;\n           dcterms:identifier ?nando_id .\n  OPTIONAL { ?disease dcterms:description ?description }\n  \n  FILTER(CONTAINS(LCASE(STR(?label)), \""parkinson\""))\n}\nLIMIT 20\n""}}, {""name"": ""mcp__togomcp__get_MIE_file"", ""input"": {""dbname"": ""nando""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""nando"", ""sparql_query"": ""\nPREFIX owl: <http://www.w3.org/2002/07/owl#>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\nPREFIX dct: <http://purl.org/dc/terms/>\nPREFIX nando: <http://nanbyodata.jp/ontology/NANDO_>\n\nSELECT ?disease ?identifier ?label ?notif_num\nFROM <http://nanbyodata.jp/ontology/nando>\nWHERE {\n  ?disease a owl:Class ;\n           rdfs:label ?label ;\n           dct:identifier ?identifier .\n  OPTIONAL { ?disease nando:hasNotificationNumber ?notif_num }\n  ?label bif:contains \""'Parkinson*'\"" option (score ?sc) .\n  FILTER(LANG(?label) = \""en\"")\n}\nORDER BY DESC(?sc)\nLIMIT 10\n""}}]",CRITICAL,NANDO:1200010,"Database: NANDO. Tests access to specialized Japanese rare disease database. Parkinson's is designated as an intractable disease in Japan. Requires NANDO database query. Verified in nando_exploration.md. Requires specialized database; not in baseline knowledge. Expert-relevant: Critical for Japanese healthcare policy, clinical trial enrollment, and international rare disease data harmonization."
11,2026-01-29,Structured Query,How many human kinases are annotated in Swiss-Prot (UniProt reviewed entries)?,True,True,True,1.0,"Based on my training knowledge, there are approximately **500-550 human protein kinases** annotated in Swiss-Prot (UniProt reviewed entries).

The human kinome is generally considered to contain around 518-538 protein kinases, depending on the specific classification criteria used. This number comes from comprehensive analyses of the human genome, and these kinases are well-characterized in Swiss-Prot due to their important roles in cell signaling, regulation, and their significance as drug targets.

The exact number can vary slightly depending on:
- The specific release version of UniProt/Swiss-Prot
- Whether atypical kinases are included
- Updates to gene annotations and classifications

The most commonly cited figure for the human kinome is around **518 protein kinases**, but I should note that the precise current count in Swiss-Prot may differ slightly from this canonical number based on the latest curation efforts.",,6.460997104644775,58,203,True,True,1.0,"Based on my query of the UniProt RDF database, there are **698 human kinases** annotated in Swiss-Prot (UniProt reviewed entries).

This count includes all human proteins (organism: *Homo sapiens*, taxonomy ID: 9606) that:
- Are manually reviewed and curated (Swiss-Prot quality standard)
- Have ""kinase"" in their recommended protein name

The examples I retrieved include well-known kinases such as:
- cAMP-dependent protein kinase catalytic subunit alpha (KAPCA_HUMAN)
- Mitogen-activated protein kinase kinase kinase kinase 1 (M4K1_HUMAN)
- Testis-specific serine/threonine-protein kinase 4 (TSSK4_HUMAN)

This represents the comprehensive, expert-curated collection of human kinases in the UniProt Swiss-Prot database, which is considered the gold standard for protein annotation quality.",,27.564463138580322,21,828,12365,127872,"mcp__togomcp__get_MIE_file, mcp__togomcp__run_sparql, mcp__togomcp__run_sparql","[{""name"": ""mcp__togomcp__get_MIE_file"", ""input"": {""dbname"": ""uniprot""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""uniprot"", ""sparql_query"": ""PREFIX up: <http://purl.uniprot.org/core/>\n\nSELECT (COUNT(DISTINCT ?protein) as ?count)\nWHERE {\n  ?protein a up:Protein ;\n           up:reviewed 1 ;\n           up:organism <http://purl.uniprot.org/taxonomy/9606> ;\n           up:recommendedName ?name .\n  ?name up:fullName ?fullName .\n  ?fullName bif:contains \""'kinase'\""\n}""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""uniprot"", ""sparql_query"": ""PREFIX up: <http://purl.uniprot.org/core/>\n\nSELECT ?protein ?mnemonic ?fullName\nWHERE {\n  ?protein a up:Protein ;\n           up:reviewed 1 ;\n           up:organism <http://purl.uniprot.org/taxonomy/9606> ;\n           up:mnemonic ?mnemonic ;\n           up:recommendedName ?name .\n  ?name up:fullName ?fullName .\n  ?fullName bif:contains \""'kinase'\""\n}\nLIMIT 10""}}]",VALUABLE,698 human kinases,"Database: UniProt. Tests complex filtering with multiple criteria: (1) organism=human, (2) reviewed=1, (3) fullName contains 'kinase'. Requires SPARQL query with bif:contains text search. Verified in uniprot_exploration.md. Entity count (proteins). Baseline cannot perform this specific multi-criteria query. Expert-relevant: Quantifies major drug target class; kinases represent ~30% of current drug development efforts."
12,2026-01-29,Structured Query,What are the direct parent terms of the Gene Ontology term 'macroautophagy' (GO:0016236)?,True,True,True,0.5,"The direct parent terms of the Gene Ontology term 'macroautophagy' (GO:0016236) are:

1. **autophagy** (GO:0006914)

Macroautophagy is a specific type of autophagy where cytoplasmic material is sequestered within double-membrane vesicles called autophagosomes, which then fuse with lysosomes for degradation. It is classified as a subtype of the broader autophagy process in the Gene Ontology hierarchy.",,3.5668790340423584,66,121,True,True,0.5,"Based on my query of the Gene Ontology database, the direct parent term of **macroautophagy** (GO:0016236) is:

- **autophagy** (GO:0006914)

This makes biological sense, as macroautophagy is a specific type of autophagy that proceeds via the formation of an autophagosome. Macroautophagy is the most well-studied form of autophagy and represents one of the main subtypes of the broader autophagy process.",,19.52251100540161,13,438,827,79388,"mcp__ols__fetch, mcp__togomcp__run_sparql","[{""name"": ""mcp__ols__fetch"", ""input"": {""id"": ""go+http://purl.obolibrary.org/obo/GO_0016236""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""go"", ""sparql_query"": ""PREFIX obo: <http://purl.obolibrary.org/obo/>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\n\nSELECT DISTINCT ?parent ?parentLabel\nWHERE {\n  obo:GO_0016236 rdfs:subClassOf ?parent .\n  FILTER(isIRI(?parent))\n  OPTIONAL { ?parent rdfs:label ?parentLabel }\n}\nORDER BY ?parent""}}]",VALUABLE,GO:0006914 (autophagy),Database: GO. Tests ontology relationship navigation. Requires OLS4 getAncestors or hierarchical query to find immediate parent. Verified in go_exploration.md. Requires database query to navigate ontology structure; baseline has limited GO hierarchy knowledge. Expert-relevant: Essential for understanding biological process relationships in systems biology and pathway analysis.
